| 000 | 01030 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250513224019.0 | ||
| 264 | 0 | _c20001220 | |
| 008 | 200012s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMillan, M J | |
| 245 | 0 | 0 |
_aImproving the treatment of schizophrenia: focus on serotonin (5-HT)(1A) receptors. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cDec 2000 |
||
| 300 |
_a853-61 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAffect _xdrug effects |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xpharmacology |
| 650 | 0 | 4 |
_aClozapine _xtherapeutic use |
| 650 | 0 | 4 |
_aCognition _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aReceptors, Dopamine _xphysiology |
| 650 | 0 | 4 |
_aReceptors, Serotonin _xanalysis |
| 650 | 0 | 4 | _aReceptors, Serotonin, 5-HT1 |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 295 _gno. 3 _gp. 853-61 |
|
| 999 |
_c11024073 _d11024073 |
||